|Academic Title||Assistant Professor|
|Department||Medicine, Hematology Oncology Division; Feinberg School of Medicine|
|Affiliations||Hematologic Malignancies (Member)|
|Address||GALTER 676 N St Clair St
|Description|| The focus of Dr. Petrich's research is on the use of novel drugs and drug combinations for the treatment of lymphomas. His laboratory research has focused on exploring epigenomic differences that account for differences is response of lymphoma cells to chemotherapy. His research has focused specifically on the Akt/mTOR pathway, with the hopes that more effective targeting of molecules in this pathway may lead to improved outcome in certain types of non-Hodgkin lymphoma. He is the local principal investigator of a number of clinical trials, and is actively recruiting patients to the many active trials available here at Northwestern.|
|Interests||Non-Hodgkin lymphoma (including diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma), AIDS-related lymphoma, post-transplant lymphoproliferative disorder, Hodgkin lymphoma.|
26044261, 24707943, 25382108, 24717566, 24786458, 24628515, 25161267, 25060588, 24282984, 23880719, 22642936, 22297843, 22338016, 22570659, 23271267, 20922788, 20881841, 20427703, 18203012
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract.
who are faculty are . who are faculty are . who are faculty are .
Similar Investigators (1):
Investigators you have not published with but by MeSH terms have significant overlap with your research